FDA Ephedrine Adverse Event Data Questioned By GAO

FDA's scientific justification for its proposed rule restricting the use of ephedrine alkaloids in dietary supplements is "open to question," GAO says in a report on the ephedrine proposed rule issued Aug. 4.

More from Archive

More from Pink Sheet